Institute for Genomic Medicine, Columbia University Irving Medical Center, New York, New York, USA.
Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA.
Am J Med Genet A. 2021 Dec;185(12):3740-3753. doi: 10.1002/ajmg.a.62445. Epub 2021 Jul 31.
Zhu-Tokita-Takenouchi-Kim (ZTTK) syndrome is caused by de novo loss-of-function variants in the SON gene (MIM #617140). This multisystemic disorder is characterized by intellectual disability, seizures, abnormal brain imaging, variable dysmorphic features, and various congenital anomalies. The wide application and increasing accessibility of whole exome sequencing (WES) has helped to identify new cases of ZTTK syndrome over the last few years. To date, there have been approximately 45 cases reported in the literature. Here, we describe 15 additional individuals with variants in the SON gene, including those with missense variants bringing the total number of known cases to 60. We have reviewed the clinical and molecular data of these new cases and all previously reported cases to further delineate the most common as well as emerging clinical findings related to this syndrome. Furthermore, we aim to delineate any genotype-phenotype correlations specifically for a recurring pathogenic four base pair deletion (c.5753_5756del) along with discussing the impact of missense variants seen in the SON gene.
Zhu-Tokita-Takenouchi-Kim (ZTTK) 综合征是由 SON 基因(MIM #617140)的新生致病变异引起的。这种多系统疾病的特征是智力残疾、癫痫发作、异常的脑成像、可变的畸形特征和各种先天性异常。全外显子组测序(WES)的广泛应用和不断提高的可及性在过去几年中帮助识别了新的 ZTTK 综合征病例。迄今为止,文献中已有约 45 例报道。在这里,我们描述了 15 名患有 SON 基因突变的额外个体,包括那些带有错义变异的个体,使已知病例总数达到 60 例。我们已经回顾了这些新病例和所有以前报告的病例的临床和分子数据,以进一步描述与该综合征相关的最常见和新出现的临床发现。此外,我们旨在描绘与反复出现的致病性四碱基缺失(c.5753_5756del)相关的任何基因型-表型相关性,并讨论在 SON 基因中看到的错义变异的影响。